It’s no secret that the only cannabis available for official use on research is provided by the University of Mississippi and NIDA, which is notoriously low in quality. The lawsuit also states that this marijuana is unfit for research because of “poor quality, unstable supply, and limited variability that in no way emulates the types of cannabis currently available through either state-regulated markets or informal markets where regulated supply is unavailable.” What makes it worse is that this cannabis is only allowed for research and not to be sold commercially, which means that it can’t be used for Phase 3 studies of the FDA, required under the Good Manufacturing Processes.
A new survey conducted by Pew Research examined what is considered “morally acceptable” in 25 countries.…
The agency has quietly sent a CBD compliance and enforcement policy to the White House…
When renowned US film director Paul Thomas Anderson and production designer Florencia Martin visited the…
A new chapter has begun for Chilean politics. After defeating candidate Jeannette Jara in the…
What it became is one of the most consequential cannabis-related cases the Supreme Court has…
Cannabis moves fast. New strains appear every season, each promising louder flavors, bigger yields, or…